APA

Selvendiran K., Bratasz A., Tong L., Ignarro L. J. & Kuppusamy P. (20080221). NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. : Cell cycle (Georgetown, Tex.).

Chicago

Selvendiran Karuppaiyah, Bratasz Anna, Tong Liyue, Ignarro Louis J and Kuppusamy Periannan. 20080221. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. : Cell cycle (Georgetown, Tex.).

Harvard

Selvendiran K., Bratasz A., Tong L., Ignarro L. J. and Kuppusamy P. (20080221). NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. : Cell cycle (Georgetown, Tex.).

MLA

Selvendiran Karuppaiyah, Bratasz Anna, Tong Liyue, Ignarro Louis J and Kuppusamy Periannan. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. : Cell cycle (Georgetown, Tex.). 20080221.